WPHM Stock Overview
Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Winston Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.29 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.99% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| WPHM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | n/a | 14.2% | 32.3% |
Return vs Industry: Insufficient data to determine how WPHM performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how WPHM performed against the US Market.
Price Volatility
| WPHM volatility | |
|---|---|
| WPHM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: WPHM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WPHM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Joel Bernstein | www.winstonlabs.com |
Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008.
Winston Pharmaceuticals, Inc. Fundamentals Summary
| WPHM fundamental statistics | |
|---|---|
| Market cap | US$77.00 |
| Earnings (TTM) | -US$2.34m |
| Revenue (TTM) | US$1.37m |
0.0x
P/S Ratio0.0x
P/E RatioIs WPHM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WPHM income statement (TTM) | |
|---|---|
| Revenue | US$1.37m |
| Cost of Revenue | US$1.84m |
| Gross Profit | -US$472.00k |
| Other Expenses | US$1.87m |
| Earnings | -US$2.34m |
Last Reported Earnings
Mar 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did WPHM perform over the long term?
See historical performance and comparison